Motoki Tsukiashi

Mr. Motoki Tsukiashi

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2018 in Briefings in Functional Genomics
Verified
Journal Article
Closed access
KKKenji Kojima
Kenji Kojima
MBMisato Baba
Misato Baba
MTMotoki Tsukiashi
Motoki Tsukiashi
TNTakuto Nishimura
Takuto Nishimura
KYKiyoshi Yasukawa
Kiyoshi Yasukawa
Ribonuclease H (RNase H) [EC 3.1.26.4] is an enzyme that specifically degrades RNA from RNA/DNA hybrids. Since its discovery in 1969, the enzyme has been extensively studied for its catalytic mechanism and physiological role. RNase H has been classified into two major families, Type 1 and Type 2. Type 1 enzymes are designated RNase HI in prokaryotes and RNase H1 in eukaryotes, while Type 2 enzymes are designated RNase HII in prokaryotes and RNase H2 in eukaryotes. Type 2 enzymes are able to cleave the 5′-phosphodiester bond of one ribonucleotide embedded in a DNA double strand. Recent studies have shown that RNase H2 is involved in excision of a single ribonucleotide embedded in genomic DNA and removal of an R-loop formed in cells. It is also involved in double-strand break of DNA and its repair. In this review, we aim to outline the structures recognized by RNase H2.

27 November 2018 in The Journal of Biochemistry
Verified
Journal Article
Closed access
PDF file
MTMotoki Tsukiashi
Motoki Tsukiashi
MBMisato Baba
Misato Baba
KKKenji Kojima
Kenji Kojima
KHKohei Himeda
Kohei Himeda
TTTeisuke Takita
Teisuke Takita
KYKiyoshi Yasukawa
Kiyoshi Yasukawa
Ribonuclease H (RNase H) specifically hydrolyzes the 5’-phosphodiester bonds of the RNA of RNA/DNA hybrid. Both types 1 and 2 RNases H act on the RNA strand of the hybrid, while only type 2 acts on the single ribonucleotide embedded in DNA duplex. In this study, to explore the role of mammalian type 2 RNase H (RNase H2) in cells, we constructed the RNase H2 knockout NIH3T3 cells (KO cells) by CRISPR/Cas9 system. KO cells hydrolyzed RNA strands in RNA/DNA hybrid, but not single ribonucleotides in DNA duplex, while wild-type NIH3T3 cells (WT cells) hydrolyzed both. Genomic DNA in the KO cells was more heavily hydrolyzed than in the WT cells by the alkaline or RNase H2 treatment, suggesting that the KO cells contained more ribonucleotides in genomic DNA than the WT cells. The growth rate of the KO cells was 60% of that of the WT cells. Expression of interferon-stimulated genes (ISGs) in the KO cells was not markedly elevated compared with the WT cells. These results suggest that in NIH3T3 cells, RNase H2 is crucial for suppressing the accumulation of ribonucleotides in genomic DNA but not for the expression of ISGs.

27 June 2017 in The Journal of Biochemistry
Verified
Journal Article
Closed access
PDF file
PKParmila Kumari
Parmila Kumari
SGSunita Ghimire Gautam
Sunita Ghimire Gautam
MBMisato Baba
Misato Baba
MTMotoki Tsukiashi
Motoki Tsukiashi
KMKoji Matsuoka
Koji Matsuoka
KNKoichi Nishigaki
Koichi Nishigaki
Genome profiling-based mutation assay (GPMA) is, to date, the only DNA sequence-based mutation assay that directly measures DNA alterations induced by mutagens. Here, the all-important congruence of mutagen assignment between DNA-based GPMA and the phenotype-based Ames test (the gold standard of mutagen assays) was confirmed qualitatively and semi-quantitatively by means of 94 chemical species (including previously examined 64). The high sensitivity (on the order of 10 ppb) and reproducibility of GPMA were also corroborated by the match between virtually independent experiments conducted in the distant past (10 years ago) and recently. Meanwhile, a standard experimental framework was established: the conditions of 100 parts per billion (ppb) concentration of a chemical and 15-generation culture of Escherichia coli. Moreover, a mammalian cell line (NIH 3T3) was shown to be suitable as a tester organism for the GPMA approach. Preliminary experimental results suggested that this approach can provide a qualitatively equivalent and quantitatively different mutagen assay results relative to the bacteria-based GPMA (renamed as bGPMA). This finding confirmed the effectiveness of the GPMA approach and indicates that mGPMA is a promising way to detect mammalian-cell mutagens.

8 May 2023 in Amino Acids
Verified
Journal Article
Closed access
PDF file
NONaomi OMI
Naomi OMI
HYHayata Yamamoto
Hayata Yamamoto
TYTaketo Yamaguchi
Taketo Yamaguchi
MTMotoki Tsukiashi
Motoki Tsukiashi
TYTakayuki Yamamoto
Takayuki Yamamoto
TKToshihiro Kawama
Toshihiro Kawama

2 July 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
MTMotoki Tsukiashi
Motoki Tsukiashi
TKTakahiro Koyama
Takahiro Koyama
HIHiroshi Iwamoto
Hiroshi Iwamoto
HSHirofumi Sonoki
Hirofumi Sonoki
KMKazuhiro Miyaji
Kazuhiro Miyaji
The emptying rate of specific nutrients in enteral formulas is poorly understood, despite the importance of controlling the emptying rate in tube-fed patients. Because of their viscosity, thickened formulas are widely used to avoid gastric reflux and reduce the burden on caregivers. This study examined how thickeners in enteral formulas affected the gastric emptying rates of proteins and carbohydrates. A semi-dynamic gastric model was used to prepare and digest test enteral formulas that contained either no thickeners or agar (0.2%). The amounts of protein and carbohydrates in each emptied aliquot were determined, and the emptying rate was calculated. We found that agar accelerated protein emptying, and an exploratory experiment with agar (0.5%) suggested the possibility of concentration dependence. Additionally, experiments using gellan gum (0.08%), guar gum (0.2%), or carrageenan (0.08%, 0.2%) suggested that protein emptying could vary depending on the thickener type and that carrageenan might slow it. These results could help with the appropriate selection of thickeners added to liquid foods based on the patient’s metabolic profile to manage nutrition, not only for tube-fed patients but also for those with oropharyngeal dysphagia or diabetes.

9 December 2025 in Foods
Verified
Journal Article
Open access
PDF file
YSYuko Setoguchi
Yuko Setoguchi
MTMotoki Tsukiashi
Motoki Tsukiashi
Hiroko Maruki-UchidaHiroko Maruki-Uchida
Hiroko Maruki-Uchida
NINAOKI IEMOTO
NAOKI IEMOTO
SEShukuko Ebihara
Shukuko Ebihara
TMTakashi Mato
Takashi Mato
Background/Objectives: Excessive smartphone use may negatively affect cognitive functions, including attention. While sensorimotor rhythm, beta, and theta waves have been linked to concentration, the electroencephalography (EEG) frequency band that most reliably serves as a neurophysiological marker of concentration is unclear. Therefore, we aimed to evaluate the effects of glucose tablet candy ingestion on attention following smartphone use in healthy adults. Methods: A randomized, double-blind, placebo-controlled crossover trial was conducted in 16 healthy adults aged 18–39 years. Participants performed a 30 min smartphone-based information search task. Attention was assessed before and after the task using the Cognitrax test battery, and participants ingested either a glucose tablet candy (containing 26 g of glucose) or a placebo (no glucose) between tests. EEG was performed during attention tests using a patch-type device. Subjective sensations, including attention, fatigue, and mental clarity (clear-headedness), were evaluated using a visual analog scale (VAS). The primary outcome was attention test scores, and secondary outcomes included EEG power and VAS ratings. Results: Glucose tablet candy ingestion after smartphone use significantly improved mean correct response time and error response scores in part 2 of the four-part continuous performance test, a subtest within Cognitrax, compared to that with the placebo. Additionally, glucose intake significantly attenuated the decrease in right prefrontal beta EEG power observed with the placebo. Improvements were also observed in self-reported physical fatigue and mental clarity on the VAS following glucose ingestion. Conclusions: The ingestion of the glucose (26 g) tablet candy improved sustained attention after smartphone use in healthy adults aged 18–39 years and was associated with changes in brain activity. These results suggest that the glucose tablet candy may help counteract the decline in concentration following cognitively demanding smartphone use.